NAFLDの治療方法としてオートファギーの誘導:現在の証拠と展望
Yanke Liu1, Mingkang Zhang2, Yazhi Wang3
1Department of Laboratory Medicine, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou 730000, China.
Biology
|September 4, 2025
まとめ
非アルコール性脂肪肝 (NAFLD) は,自己消化機能の障害と関連しています. この細胞過程の回復は NAFLDの治療に有望であり,様々な治療介入に関する研究が進行中です.
科学分野:
- 細胞生物学
- ヘパトロジー
- 分子医学
背景:
- 非アルコール性脂肪肝 (NAFLD) は,肝臓機能障害を引き起こす世界的な健康問題です.
- NAFLDの進行を促す正確なメカニズムは完全に理解されていません.
- 細胞のリサイクルプロセスであるオートファギーはNAFLDの病原化にますます関与しています.
研究 の 目的:
- オートファジーとNAFLDの複雑な関係を見直す
- NAFLDの管理のためにオートファギーを標的とした現在のおよび新興の治療戦略を探求する.
- 新しいNAFLD治療のための潜在的な分子標的を特定する.
主な方法:
- NAFLDにおけるオートファギーを調査する研究の包括的な文献レビュー.
- ライフスタイル,薬理学,その他の新しいアプローチを含む様々な介入に関する研究の分析.
- 分子メカニズムと潜在的な治療目標の議論
主要な成果:
- 証拠は NAFLD の発症と進行を,自己消化障害と強く結びつけています.
- 自己消化機能の回復は 肝臓の損傷を軽減するための潜在的な戦略です
- ダイエットから植物由来の化合物まで,NAFLDにおける自閉症を調節するための様々な介入が検討されています.
結論:
- オートファギーはNAFLDの病理生理学において中心的な役割を果たします.
- オートファギーをターゲットにすることは NAFLDの治療に有望な道を示しますが,課題は残っています.
- 効果的なNAFLD治療の開発には,オートファジーに関連する分子標的に関するさらなる研究が不可欠です.
関連する概念動画
Delivery Pathways to the Lysosome
7.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K
Autophagy
5.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.1K
Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
NF-κB-dependent Signaling Pathway
7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.7K
Autophagic Cell Death
3.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


